Commentary · 3 Jan 2024
Conference abstractPublished 5 Oct 2017
Platelets in the Hematooncological diseases
Research and Development Dept, Netherlands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
After 21th Century Medical Scientists are looking for ultimate remedy to cure Hematooncological patients and related diseases, which later still cause high mortality and morbidity world widely. Average treatment be made up of 1.induction and 2.post remission stages (1). The determined of the former is to produce, and of the latter to prolong, a complete remission defined as a marrow with 1 000 neutrophils and >100 000 circulating blood platelets (1). The ultimate goals of (early-) prognostics/diagnostics and treatments are 1. reproduction and recovery of bone marrow cell regeneration and thereby 2. prolongation of patientsâÂ?Â? survival and go back to their normal life. To increase reproduction of (pro-)platelets from megakaryocytes above 100000/microliter subject’s body needs collaboration of 7 major processes 1. decrease of consumption 2. removal of infection 3. removal of chemicals from bone marrow and/or blood circulation 4. increased TPO hormone production 5. availability of vitamins and relevant metabolites 6. accessibility of oxidative phosphorylation and glycolysis 7. removal of poisons and metabolites that prevent reproduction of pro-platelets and/or antigens, which promotes pro-platelets aggregation and agglutinations (procoagulants). Here our team is collaborating in a pilot study to unravel how platelets could be reproduced above 100000 in the Hematooncological patients could be treated in less than two month.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 27 Dec 2023
Extending Blood coagulation: A Comprehensive Examination of Platelets in both Health and Disease
Editorial · 5 Jan 2018
Significance of platelet volume indices in coronary artery diseases
Conference abstract · 5 Oct 2017
Sticky platelet syndrome and MPN disease burden in JAK2 thrombocythemia and polycythemia vera, and in JAK2, mpl and calr thrombocythemias: Implications for novel non-leukemogenic treatment options in prefibrotic myelopro
Research article · 27 Mar 2023
Comparison of Aspartate Aminotransferase Platelet Ratio Index (APRI) Score and Insulin Resistance in Type 2 Diabetes Mellitus with Non-Alcoholic Fatty Liver Disease
More from this journal
The newest in Journal of Hematology & Thromboembolic Diseases.
Mini review · 13 Feb 2026
Factors Influencing Attitudes of Adults towards Hypertension Management in Nigeria: A Mini-Review
Opinion · 25 Dec 2025
Clinical Patterns and Systemic Implications of Thromboembolism
Opinion · 25 Dec 2025
Integrating Clinical Risk and Preventive Care in Thromboembolism Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hematology & Thromboembolic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Bahram Alamdary Badlou”

